What is MaxCyte's inventories?

MaxCyte (MXCT) reported inventories of $7.63M in Q1 2026.

How has MaxCyte's inventories changed year-over-year?

MaxCyte's inventories decreased by 7.8% year-over-year, from $8.27M to $7.63M.

What is the long-term trend for MaxCyte's inventories?

Over 4 years (2021 to 2025), MaxCyte's inventories has grown at a 22.8% compound annual growth rate (CAGR), from $13.81M to $31.37M.

What does inventories mean?

Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.

MaxCyte MXCT Inventories

Inventories at other companies

Rapid Micro BiosystemsRPID

$17.45M-15.8%

PDE

Pro-Dex, Inc.PDEX

$22.36M-4.6%

RepligenRGEN

$179.26M+17.1%

TEC

Bio-TechneTECH

$201.18M+5.3%

Envista Holdings CorporationNVST

$300.3M+14.9%

Apyx Medical CorporationAPYX

$9.54M+24.1%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's inventories?: MaxCyte (MXCT) reported inventories of $7.63M in Q1 2026.
How has MaxCyte's inventories changed year-over-year?: MaxCyte's inventories decreased by 7.8% year-over-year, from $8.27M to $7.63M.
What is the long-term trend for MaxCyte's inventories?: Over 4 years (2021 to 2025), MaxCyte's inventories has grown at a 22.8% compound annual growth rate (CAGR), from $13.81M to $31.37M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.